Sarah Lapointe

1.7k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

Sarah Lapointe is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Sarah Lapointe has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Neurology. Recurrent topics in Sarah Lapointe's work include Glioma Diagnosis and Treatment (11 papers), Brain Metastases and Treatment (5 papers) and Meningioma and schwannoma management (5 papers). Sarah Lapointe is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Brain Metastases and Treatment (5 papers) and Meningioma and schwannoma management (5 papers). Sarah Lapointe collaborates with scholars based in Canada and United States. Sarah Lapointe's co-authors include Arie Perry, Nicholas Butowski, Priti Gros, Richard Wennberg, Catherine Maurice, Julien Hébert, Claude Steriade, Gregory S. Day, David F. Tang‐Wai and Fatima Amtashar and has published in prestigious journals such as The Lancet, Neurology and Journal of Neuroimmunology.

In The Last Decade

Sarah Lapointe

14 papers receiving 1.1k citations

Hit Papers

Primary brain tumours in adults 2018 2026 2020 2023 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Primary brain tumours in adults
    2018 983 citations Sarah Lapointe, Arie Perry et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Lapointe Canada 5 485 438 312 215 134 18 1.1k
Donita Lightner United States 7 375 0.8× 571 1.3× 265 0.8× 224 1.0× 152 1.1× 14 1.1k
Aurelio Hernández‐Laín Spain 19 456 0.9× 572 1.3× 191 0.6× 165 0.8× 205 1.5× 88 1.3k
Patrick Y Wen United States 9 827 1.7× 712 1.6× 502 1.6× 222 1.0× 150 1.1× 16 1.6k
Cecilie Brekke Rygh Norway 15 484 1.0× 387 0.9× 379 1.2× 93 0.4× 168 1.3× 33 1.2k
Pei Yang China 22 530 1.1× 613 1.4× 520 1.7× 322 1.5× 133 1.0× 46 1.3k
Ryusuke Hatae Japan 17 295 0.6× 554 1.3× 227 0.7× 154 0.7× 216 1.6× 56 979
Caroline Happold Germany 17 544 1.1× 479 1.1× 367 1.2× 182 0.8× 51 0.4× 25 1.1k
Garth Cruickshank United Kingdom 15 345 0.7× 305 0.7× 239 0.8× 154 0.7× 166 1.2× 23 899
M. Lahutte France 10 339 0.7× 483 1.1× 196 0.6× 224 1.0× 174 1.3× 28 1.0k

Countries citing papers authored by Sarah Lapointe

Since Specialization
Citations

This map shows the geographic impact of Sarah Lapointe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Lapointe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Lapointe more than expected).

Fields of papers citing papers by Sarah Lapointe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Lapointe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Lapointe. The network helps show where Sarah Lapointe may publish in the future.

Co-authorship network of co-authors of Sarah Lapointe

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Lapointe. A scholar is included among the top collaborators of Sarah Lapointe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Lapointe. Sarah Lapointe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lapointe, Sarah, et al.. (2025). Tumor-Treating Fields and Related Treatments in the Management of Pediatric Brain Tumors. Current Oncology. 32(4). 185–185. 1 indexed citations
2.
Bélanger, Karl, Sarah Lapointe, Bernard Lemieux, et al.. (2025). A Retrospective Study on Prognostic Factors and Systemic Treatments of Refractory Meningiomas. Current Oncology. 32(9). 516–516.
3.
Mason, Warren, Rebecca A. Harrison, Sarah Lapointe, et al.. (2025). Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study. Current Oncology. 32(4). 207–207. 3 indexed citations
4.
Das, Sunit, Sébastien Perreault, Stephen Yip, et al.. (2023). INNV-35. IMPLEMENTATION OF A NATIONAL ADOLESCENT AND YOUNG ADULT MOLECULAR TUMOR BOARD: REPORT FROM THE CANADIAN AYA NEURO-ONCOLOGY NETWORK. Neuro-Oncology. 25(Supplement_5). v164–v164.
5.
Lim-Fat, Mary Jane, Sarah Lapointe, Chantel Cacciotti, et al.. (2022). Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline. Frontiers in Oncology. 12. 960509–960509. 10 indexed citations
6.
Lemieux, Bernard, Sarah Lapointe, Karl Bélanger, et al.. (2022). BIOS-02. CLINICAL OUTCOMES OF OVER 600 PATIENTS WITH GLIOBLASTOMA TREATED AT A CANADIAN TERTIARY CENTER IN THE PAST 15 YEARS: A COMPARATIVE ANALYSIS WITH THE PIVOTAL STUPP TRIAL. Neuro-Oncology. 24(Supplement_7). vii20–vii21. 1 indexed citations
7.
Bahary, Jean-Paul, et al.. (2022). PATH-10. A CASE OF ADULT THALAMIC DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED WITH AN IMPRESSIVE RESPONSE TO RADIOTHERAPY AND CONCOMITANT PLUS ADJUVANT TEMOZOLOMIDE. Neuro-Oncology. 24(Supplement_7). vii151–vii152. 1 indexed citations
8.
Hébert, Julien, Priti Gros, Sarah Lapointe, et al.. (2020). Searching for autoimmune encephalitis: Beware of normal CSF. Journal of Neuroimmunology. 345. 577285–577285. 33 indexed citations
9.
10.
Lapointe, Sarah, Warren Mason, Mary MacNeil, et al.. (2019). A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study. Investigational New Drugs. 38(4). 1137–1144. 31 indexed citations
11.
Buerki, Robin, Sarah Lapointe, Joanna J. Phillips, et al.. (2019). Clinical and pathological characteristics of 52 adults with H3 K27M-mutant diffuse midline gliomas at UCSF (S14.004). Neurology. 92(15_supplement). 1 indexed citations
12.
Lapointe, Sarah, Arie Perry, & Nicholas Butowski. (2018). Primary brain tumours in adults. The Lancet. 392(10145). 432–446. 983 indexed citations breakdown →
13.
Buerki, Robin, Sarah Lapointe, David A. Solomon, et al.. (2018). PATH-09. CLINICAL CHARACTERISTICS OF ADULTS WITH H3 K27M-MUTANT GLIOMAS AT UCSF. Neuro-Oncology. 20(suppl_6). vi159–vi160. 3 indexed citations
14.
Lapointe, Sarah, et al.. (2016). Intramedullary Spinal Cord Abscess; Descriptive Review of the Literature (P2.015). Neurology. 86(16_supplement). 2 indexed citations
15.
Lapointe, Sarah, Marie Florescu, David Simonyan, & Karine Michaud. (2016). Impact of standard care on elderly glioblastoma patients. Neuro-Oncology Practice. 4(1). 4–14. 4 indexed citations
16.
Lapointe, Sarah, et al.. (2015). Prophylactic anticonvulsants for gliomas: a seven-year retrospective analysis. Neuro-Oncology Practice. 2(4). 192–198. 12 indexed citations
17.
Lapointe, Sarah, Catherine Legault, & Robert Altman. (2015). Nocardial Intramedullary Abscess; A Case Report and Review of Literature (P2.332). Neurology. 84(14_supplement). 1 indexed citations
18.
Lapointe, Sarah, Catherine Legault, Paul S. Giacomini, et al.. (2015). NMDA-receptor encephalitis: An unsual case of refractory status epilepticus. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 42(S1). S33–S33.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donita Lightner Breakdown of academic impact, for papers by Aurelio Hernández‐Laín Breakdown of academic impact, for papers by Patrick Y Wen Breakdown of academic impact, for papers by Cecilie Brekke Rygh Breakdown of academic impact, for papers by Pei Yang Breakdown of academic impact, for papers by Ryusuke Hatae Breakdown of academic impact, for papers by Caroline Happold Breakdown of academic impact, for papers by Garth Cruickshank Breakdown of academic impact, for papers by M. Lahutte
Rankless by CCL
2026